Arnall, Justin R <br/><br/>
Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.  [electronic resource] 

 -  Leukemia & lymphoma  09 2019 
 - 2295-2298 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2019.1576871  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetaminophen--therapeutic use<br/>Ambulatory Care--methods<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Cancer Care Facilities<br/>Diphenhydramine--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug-Related Side Effects and Adverse Reactions--etiology<br/>Feasibility Studies<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Infusions, Intravenous--adverse effects<br/>Multiple Myeloma--drug therapy<br/>Outpatient Clinics, Hospital<br/>Premedication--methods<br/>Retrospective Studies<br/>Time Factors